Alpa Laboratories Limited Stock

Equities

ALPA

INE385I01010

Pharmaceuticals

Delayed NSE India S.E. 03:36:08 2024-04-25 am EDT 5-day change 1st Jan Change
96.45 INR +0.68% Intraday chart for Alpa Laboratories Limited +7.53% -6.63%
Sales 2022 1.23B 14.76M Sales 2023 930M 11.15M Capitalization 1.13B 13.58M
Net income 2022 141M 1.69M Net income 2023 126M 1.51M EV / Sales 2022 0.67 x
Net cash position 2022 644M 7.73M Net cash position 2023 785M 9.42M EV / Sales 2023 0.37 x
P/E ratio 2022
10.4 x
P/E ratio 2023
9 x
Employees 318
Yield 2022 *
-
Yield 2023
-
Free-Float 42.71%
More Fundamentals * Assessed data
Dynamic Chart
Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Alpa Laboratories Limited Announces Reconstitution of Committees CI
Alpa Laboratories Limited Announces Directors Appointments CI
Alpa Laboratories Limited Appoints Shitul Shah as an Additional Director CI
Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Alpa Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022 CI
Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2021 CI
Alpa Laboratories Limited Appoints Swati Bagh as Company Secretary Cum Compliance Officer CI
Alpa Laboratories Limited Announces Resignation of Aditya Singh as Company Secretary and Compliance Officer CI
Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021 CI
More news
1 day+0.68%
1 week+7.53%
Current month+15.86%
1 month+12.81%
3 months-4.65%
6 months+37.49%
Current year-6.63%
More quotes
1 week
89.50
Extreme 89.5
97.80
1 month
82.95
Extreme 82.95
97.80
Current year
81.00
Extreme 81
115.00
1 year
55.00
Extreme 55
115.00
3 years
46.75
Extreme 46.75
115.00
5 years
11.00
Extreme 11
115.00
10 years
7.70
Extreme 7.7
115.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO 63 -
Compliance Officer 31 21-08-13
Members of the board TitleAgeSince
Founder 75 66-12-31
Director/Board Member 68 10-12-27
Director/Board Member 73 08-07-28
More insiders
Date Price Change Volume
24-04-25 96.45 +0.68% 18 659
24-04-24 95.8 +1.05% 52,582
24-04-23 94.8 +1.66% 51,300
24-04-22 93.25 +1.25% 25,632
24-04-19 92.1 +2.68% 90,374

Delayed Quote NSE India S.E., April 25, 2024 at 03:36 am EDT

More quotes
Alpa Laboratories Limited is an India-based company, which is engaged in manufacturing and selling pharmaceutical finished dosage forms. The Company’s product range includes a wide variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
More about the company